Ocugen stock is a good speculative buy but there’s 1 key risk

Ocugen (NASDAQ: OCGN) stock price has launched higher since last year, helped by the rising hopes that OCU400 will be approved by the Food and Drug Administration (FDA). The stock surged by over 378% from its lowest point in September and by 183% this year.  OCU400 could be a gamechanger Ocugen is a biotech company […]